Debridement device and method

Information

  • Patent Grant
  • 12329443
  • Patent Number
    12,329,443
  • Date Filed
    Friday, August 11, 2023
    a year ago
  • Date Issued
    Tuesday, June 17, 2025
    28 days ago
Abstract
Devices, systems and methods for cutting and sealing of tissue such as bone and soft tissue. Devices, systems and methods include delivery of energy including bipolar radiofrequency energy for sealing tissue which may be concurrent with delivery of fluid to a targeted tissue site. Devices include debridement devices which may include a fluid source. Devices include inner and outer shafts coaxially maintained and having cutters for debridement of tissue. An inner shaft may include electrodes apart from the cutter to minimize trauma to tissue during sealing or hemostasis. Devices may include a single, thin liner or sheath for electrically isolating the inner and outer shafts.
Description
BACKGROUND

The present disclosure is generally directed to devices, systems and methods for cutting and sealing tissue such as bone and soft tissue. The present disclosure may be particularly suitable for sinus applications and nasopharyngeal/laryngeal procedures and may combine or provide Transcollation® technology with a microdebrider device.


Devices, systems and methods according to the present disclosure may be suitable for a variety of procedures including ear, nose and throat (ENT) procedures, head and neck procedures, otology procedures, including otoneurologic procedures. The present disclosure may be suitable for a varient of other surgical procedures including mastoidectomies and mastoidotomies; nasopharyngeal and laryngeal procedures such as tonsillectomies, trachael procedures, adenoidectomies, laryngeal lesion removal, and polypectomies; for sinus procedures such as polypectomies, septoplasties, removals of septal spurs, anstrostomies, frontal sinus trephination and irrigation, frontal sinus opening, endoscopic DCR, correction of deviated septums and trans-sphenoidal procedures; rhinoplasty and removal of fatty tissue in the maxillary and mandibular regions of the face.


Sinus surgery is challenging due to its location to sensitive organs such as the eyes and brain, the relatively small size of the anatomy of interest to the surgeon, and the complexity of the typical procedures. Examples of debriders with mechanical cutting components are described in U.S. Pat. Nos. 5,685,838; 5,957,881 and 6,293,957. These devices are particularly successful for powered tissue cutting and removal during sinus surgery, but do not include any mechanism for sealing tissue to reduce the amount of bleeding from the procedure. Sealing tissue is especially desirable during sinus surgery which tends to be a complex and precision oriented practice.


Electrosurgical technology was introduced in the 1920's. In the late 1960's, isolated generator technology was introduced. In the late 1980's, the effect of RF lesion generation was well known. See e.g., Cosman et al., Radiofrequency lesion generation and its effect on tissue impedance, Applied Neurophysiology (1988) 51: 230-242. Radiofrequency ablation is successfully used in the treatment of unresectable solid tumors in the liver, lung, breast, kidney, adrenal glands, bone, and brain tissue. See e.g., Thanos et al., Image-Guided Radiofrequency Ablation of a Pancreatic Tumor with a New Triple Spiral-Shaped Electrode, Cardiovasc. Intervent. Radiol. (2010) 33:215-218.


The use of RF energy to ablate tumors or other tissue is known. See e.g., Mc Gahan J P, Brock J M, Tesluk H et al., Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Intery Radiol 1992; 3:291-297. Products capable of aggressive ablation can sometimes leave undesirable charring on tissue or stick to the tissue during a surgical procedure. Medical devices that combine mechanical cutting and an electrical component for cutting, ablating or coagulating tissue are described, for example, in U.S. Pat. Nos. 4,651,734 and 5,364,395.


Commercial medical devices that include monopolar ablation systems include the Invatec MIRAS RC, MIRAS TX and MIRAS LC systems previously available from Invatec of Italy. These systems included a probe, a grounding pad on the patient and a generator that provides energy in the range of 450 to 500 kHz. Other examples of RF bipolar ablation components for medical devices are disclosed in U.S. Pat. Nos. 5,366,446 and 5,697,536.


Medical devices are also used to ablate heart tissue with RF energy. See, e.g., Siefert et al. Radiofrequency Maze Ablation for Atrial Fibrillation, Circulation 90(4): 1-594. Some patents describing RF ablation of heart tissue include U.S. Pat. Nos. 5,897,553, 6,063,081 and 6,165,174. Devices for RF ablation of cardiac tissue are typically much less aggressive than RF used to cut tissue as in many procedures on cardiac tissue, a surgeon only seeks to kill tissue instead of cutting or removing the tissue. Cardiac ablation of this type seeks to preserve the structural integrity of the cardiac tissue, but destroy the tissue's ability to transfer aberrant electrical signals that can disrupt the normal function of the heart.


Transcollation® technology, for example, the sealing energy supplied by the Aquamantys® System (available from Medtronic Advanced Energy of Portsmouth, N.H.) is a patented technology which stops bleeding and reduces blood loss during and after surgery and is a combination of radiofrequency (RF) energy and saline that provides hemostatic sealing of soft tissue and bone and may lower transfusion rates and reduce the need for other blood management products during or after surgery. Transcollation® technology integrates RF energy and saline to deliver controlled thermal energy to tissue. Coupling of saline and RF energy allows a device temperature to stay in a range which produces a tissue effect without the associated charring found in other ablation methods.


Other ablation devices include both mechanical cutting as well as ablation energy. For example, the PK Diego® powered dissector is commercially available from Gyms ENT of Bartlett, Tenn. This device utilizes two mechanical cutting blade components that are moveable relative to each other, one of which acts as an electrode in a bipolar ablation system. The distal end portion of the device includes six layers to accomplish mechanical cutting and electrical coagulation. The dual use of one of the components as both a mechanical, oscillating cutting element and a portion of the bipolar system of the device is problematic for several reasons. First, the arrangement exposes the sharp mechanical cutting component to tissue just when hemostasis is sought. In addition, the electrode arrangement does not provide for optimal application of energy for hemostasis since the energy is applied essentially at a perimeter or outer edge of a cut tissue area rather than being applied to a central location of the cut tissue. The arrangement of the device also requires more layers than necessary in the construction of a device with both sharp cutters and RF ablation features. The overabundance of layers can make it difficult to design a small or optimally-sized distal end. Generally speaking, the larger the distal end, the more difficult it is for the surgeon to visualize the working surfaces of the device. The use of six layers at the distal end of the system also interferes with close intimate contact between the tissue and the electrodes. Some examples of cutting devices are described in U.S. Pat. Nos. 7,854,736 and 7,674,263.


The Medtronic Straightshot® M4 Microdebrider uses sharp cutters to cut tissue, and suction to withdraw tissue. While tissue debridement with the Medtronic microdebrider system is a simple and safe technique, some bleeding may occur. The Medtronic microdebrider does not include a feature dedicated to promoting hemostasis or bleeding management. Thus, nasal packing is often used.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings, where like numerals refer to like components throughout several views:



FIG. 1 is a perspective view of a system according to one aspect of the present disclosure;



FIG. 2 is a perspective view of a distal end region of a device with an inner shaft in a position according to one aspect of the present disclosure;



FIG. 3 is a perspective view of the distal end region of a device with an inner shaft in an alternative position according to one aspect of the present disclosure;



FIG. 4 is a perspective view the distal end region of FIG. 2 with an outer shaft removed to show portions of an inner shaft and insulation liner;



FIG. 5 is a perspective view of the distal end region of FIG. 4 with the insulation liner removed to show additional portions of the inner shaft and electrode traces;



FIG. 6 is a perspective view of the distal end region of FIG. 5 with the electrode traces removed;



FIG. 7 is a perspective view of the distal end region of FIG. 6 with components removed;



FIG. 8 is a perspective view of another embodiment of a distal end portion of an outer shaft of a device according the present disclosure;



FIG. 9 is a perspective view the outer shaft of FIG. 8 showing a partial electrode configuration according to an aspect of the present disclosure;



FIG. 10 is a perspective view of a proximal end of an inner shaft according to an aspect of the present disclosure;



FIG. 11 is a perspective view of a proximal end of a device showing a button activation cell according to an aspect of the present disclosure;



FIG. 12 is a an exploded view of the button activation cell of FIG. 11 according to an embodiment of the present disclosure;



FIG. 13 is a perspective view of portions of the button activation cell of FIG. 11 according to an aspect of the present disclosure;



FIG. 14 is a perspective view of the assembly of FIG. 13 with portions removed according to an aspect of the present disclosure; and



FIG. 15 is a top view of the button activation cell of FIG. 10 according to an aspect of the present disclosure.





DETAILED DESCRIPTION


FIG. 1 illustrates a system 10 according to an aspect of the present disclosure. The system 10 includes a device 100 having a distal end region indicated generally at 120 and a proximal end region indicated generally at 110. The device includes an outer shaft 130 and an inner shaft 140 coaxially maintained within the outer shaft 130. A portion of the inner shaft 140 is shown in FIG. 1 at distal end region 120. Proximal end region 110 includes a button activation cell 200 comprising a housing 204 and a button 202, the proximal end region further comprising a hub 175 coupled to inner shaft 140. The hub is configured to couple to a handle or handpiece 177 which can be manipulated by a user (e.g., a surgeon). The handpiece 177, in turn may be coupled to an integrated power console or IPC 179 for driving the device 100 and specifically for controlling rotation of inner shaft 140. The IPC 179 may also include a fluid source (not shown) and may provide fluid delivery to device 100.


Proximal end region 110 also includes a fluid source connector 150, a power source connector 160 and a suction source connector 170 for connection to a fluid source 152, a power source, 162 and/or a suction source of system 10. One fluid useful with the present disclosure is saline, however, other fluids are contemplated. Power source 162 may be a generator and optionally may be designed for use with bipolar energy or a bipolar energy supply. For example, the Transcollation® sealing energy supplied by the Aquamantys® System (available from Medtronic Advanced Energy of Portsmouth, N.H.) may be used. Both the fluid source 152 and suction source 172 are optional components of system 10. However, use of fluid in conjunction with energy delivery aids in providing optimal tissue effect as will be further explained, thus embodiments of the present disclosure include specific arrangement of the device 100 for coupling of energy with a fluid. In use, a fluid (e.g., saline) may be emitted from an opening at the distal end region of the device 100. Tissue fragments and fluids can be removed from a surgical site through an opening (not shown in FIG. 1) in the distal end region via the suction source 172, as will be further explained below.



FIG. 2 shows an enlarged perspective view of distal end portion 120 of device 100. The outer shaft 130 includes a window or opening 134 at a distal end 135 of the outer shaft 135. Window 134 is defined by an outer shaft cutting edge or cutter 132, which comprises cutting teeth 133. The outer shaft 130 may be rigid or malleable or combinations thereof and may be made of a variety of metals and/or polymers or combinations thereof, for example may be made of stainless steel. A distal portion 148 of the inner shaft 140 can be seen through the window or opening 134 of outer shaft 130. In FIG. 1, inner shaft 140 is depicted in a position such that an inner shaft cutting edge or cutter 141 (FIG. 3), comprising cutting teeth 143 is facing an inner wall (not shown) of outer shaft 130. Cutter 141 defines an inner shaft window or opening 154 (FIG. 3).


Outer and inner shaft cutters 132 and 141 may move relative to one another in oscillation or rotation (or both) in order to mechanically cut tissue. For example, outer shaft cutter 132 may remain stationary relative to the hub 175 and button assembly 200 while the inner shaft cutter 141 may rotate about a longitudinal axis A of the device, thereby cutting tissue.


Rotation of inner shaft 140 may be achieved via manipulation of hub 175 (FIG. 1). that can orient the inner shaft 140 relative to the outer shaft 130 and may additionally allow for locking of the inner shaft relative to the outer shaft in a desired position, i.e., inner shaft may be locked in position when cutter 141 is facing down and electrode assembly 142 is facing up. As described above, hub 175 may be connected to a handle or handpiece 177 which may be controlled by an IPC 179. Alternatively, the hub 175 and/or handle portions may be manipulated manually. Inner shaft 140 may be selectively rotated to expose an electrode assembly 142 comprising electrodes 142a, 142b, through opening 134 of outer shaft 130, as shown in FIG. 2. Electrodes 142a, 142b may comprise electrode traces and the electrode traces may extend from the distal portion 148 of the inner shaft to a proximal end 151 (FIG. 10) of the inner shaft 140. As depicted in FIG. 2, inner shaft 140 is positioned such that the inner shaft cutter 141 is facing the interior (not shown) of outer shaft 130 and may be said to be in a downward facing direction and comprise a downward position. In the downward position, tissue is shielded from the inner shaft cutter 141 during hemostasis (via energy delivery through electrodes 142a, 142b), thereby delivering energy to tissue with no attendant risk that the cutting teeth 143 of the inner shaft 140 will diminish the efforts to achieve hemostasis. Device 100 may thus comprise two modes: a cutting or debridement mode and a sealing or hemostasis mode and the two modes may be mutually exclusive, i.e. hemostasis is achieved via energy delivery to tissue while cutters 132, 141 are not active or cutting. As described below, energy may be advantageously delivered simultaneously with a fluid such as saline to achieve an optimal tissue effect by delivering controlled thermal energy to tissue.


As depicted in FIG. 3, when the inner shaft 140 is oriented such that the cutter 141 is in the downward position, rotating inner shaft 140 approximately 180 degrees relative to the outer shaft 130 will expose inner shaft cutter 141 and inner shaft opening 154 through the outer shaft opening 134. When the inner shaft cutter 141 is positioned as shown in FIG. 3, the inner shaft cutter 141 may be said to be in an upward position. The inner shaft opening 154 is fluidly connected to an inner shaft lumen 156, a portion of which can be seen in FIG. 7. Lumen 156 extends from the inner shaft distal portion 148 to the proximal end 151 (FIG. 10) of inner shaft 140 and may be fluidly connected with the suction source 172. With this configuration, tissue cut via inner and outer shaft cutters 141, 132 may be aspirated into the inner shaft lumen 156 through the inner shaft opening 154 upon application of suction source 172, thereby removing tissue from a target site.


With reference between FIGS. 4 and 5, the inner shaft 140 comprises a proximal assembly 168 including a proximal assembly shaft component 169 (more clearly seen in FIG. 5) and electrodes 142a and 142b. Inner shaft 140 also includes a joining assembly 144, which may be a non-conductive component and more specifically may comprise a liquid crystal polymer (LCP) overmold assembly. The joining assembly 144 may effectively join or connect the distal portion 148 of inner shaft 140 with the proximal assembly shaft component 169 (most clearly depicted in FIG. 5). Joining assembly 144 includes an extension portion 146 which aids in minimizing arc tracking from the electrodes 142a and 142b as will be further elucidated in the following discussion.


Electrodes or electrode traces 142a and 142b comprise bipolar electrodes and may comprise wet or dry electrodes. Electrodes 142a and 142b may be used to deliver any suitable energy for purposes of coagulation, hemostasis or sealing of tissue. Electrodes 142a and 142b are particularly useful with fluid such as saline provided by fluid source 152 (FIG. 1) which may be emitted near the outer shaft opening 134. Outer shaft opening 134 is fluidly connected to an outer shaft lumen 136, shown in phantom in FIG. 7. Lumen 136 extends from outer shaft opening 134 to the proximal end region 110 of device 100 and may be fluidly connected to the fluid source 152 (FIG. 1). Thus, fluid can be delivered to the opening 134 of outer shaft 130 and interacts with electrode traces 142a, 142b, as will be further described with reference to FIG. 1. In this manner, electrode traces 142a and 142b can advantageously provide Transcollation® sealing of tissue when used with the Transcollation® sealing energy supplied by the Aquamantys System, available from the Advanced Energy Division of Medtronic, Inc. With respect to “wet” RF coagulation technology, the technology for sealing tissue described in U.S. Pat. Nos. 6,558,385; 6,702,810, 6,953,461; 7,115,139, 7,311,708; 7,537,595; 7,645,277; 7,811,282; 7,998,140; 8,048,070; 8,083,736; and 8,361,068 (the entire contents of each of which is incorporated by reference) describe bipolar coagulation systems believed suitable for use in the present disclosure. Other systems for providing a source of energy are also contemplated.


Both FIGS. 4 and 5 depict the distal end region 120 of device 100, with outer shaft 130 removed. FIG. 4 shows a portion of the inner shaft 140 coaxially maintained in an insulation liner or sheath 180. The liner 180 may extend from a location proximal the inner shaft cutter 141 and cutting teeth 143, along inner shaft 140, to the proximal end 151 of inner shaft 140. Liner 180 provides insulation between the inner and outer shafts 130, 140, thus providing electrical isolation of the electrodes 142a and 142b from outer shaft 130 as well as from one another while only adding a single, very thin layer to the overall device 100. Liner 180 may be made of any suitable material, for example, fluorinated ethylene propylene (FEP), polytetrafluoroethylene (PTFE), or any other material suitable as a non-conductive or electrically insulative material. Regardless, liner 180 is constructed so as to be negligible in its contribution to the overall diameter of the device 100 and particularly the distal end region 120 of the device 100.



FIG. 5 shows the distal end region 120 of device 100 with both the outer shaft 130 and the insulation liner 180 removed, thus exposing only portions of inner shaft 140. As described above, inner shaft 140 includes a distal portion 148, which includes cutter 141, and an inner shaft proximal assembly 168 including proximal assembly shaft component 169. The individual distal portion 148 and shaft component 169 can be seen more clearly in FIG. 7 in which the joining assembly 144 and electrodes 142a, 142b are removed. The proximal assembly shaft component 169 may comprise a variety of suitable materials and for example, may comprise a liquid crystal polymer (LCP) extruded shaft component that is configured to support the placement of metallized conductors (e.g., electrodes 142a, 142b) and may support overmolding (e.g. of joining assembly 144) and/or a plating process, such as described below. Proximal assembly shaft component 169 may undergo a laser etching process to form the depressed areas 145 suitable for electrode placement or plating. Other methods of forming the depressed areas 145 are also contemplated. FIG. 6 shows inner shaft 140 with the electrodes or electrode traces 142a, 142b removed from the proximal portion 168 and joining assembly 144. Electrodes 142a and 142b may be formed on the proximal assembly shaft component 169 and on a portion of joining assembly 144 in a plating process for forming electrode traces. The portion over which the electrode traces may be applied includes depressed areas 145 (FIG. 6), which may be laser etched areas. One process of electrode plating may include first applying copper sufficient to conduct the desired power and then adding nickel and gold layers to the laser etched area 145. Other metals and combinations of metals are also contemplated, for example, silver may be used or any other metal or combination of metals effective in providing a cross section which meets power requirements for the energy delivery. Regardless, the plating process and overall electrode 142a, 142b thickness or depth is configured such that the electrodes 142a, 142b do not negatively impact the diameter of the device 100. As but one example, the electrode plating process may result in a dimensional change to the overall diameter as little as 0.0015″.



FIG. 5 also more fully depicts joining assembly 144 which joins the distal portion 148 with the inner shaft proximal assembly 168 of the inner shaft 140. As seen in FIG. 5, portions of distal portion 148 and proximal assembly shaft component 169 may be configured in a “puzzle piece” arrangement as is indicated at joining assembly 144 which follows the lines of the puzzle piece. Each of the distal portion 148 and proximal assembly shaft component 169 include a mating edge 192, 190, respectively. This configuration distributes forces acting on the inner shaft 140 when the device 100 is in a cutting mode to aid in a secure coupling of the distal portion 148 and shaft component 169. The joining assembly extension portion 146 is located between electrodes 146a and 146b. This extension portion 146 provides adequate space between the electrodes 146a, 146b to mitigate arc tracking between the two and to improve the tissue depth effect.


Returning to FIG. 1, when fluid from fluid source 152 is provided through lumen 136 of the outer shaft 130, the fluid may travel between the outside diameter of the inner shaft 140 and the inside diameter of the outer shaft 130 to the distal end 120 of device 100. Fluid travels distally down the lumen 136 of outer shaft 130 and may “pool” in an area shown in FIG. 1 as essentially defined by the opening 134 of outer shaft 130. Likewise, electrodes 142a and 142b may be located slightly below the surface of the joining assembly 144 and/or the inner shaft proximal portion 168 (FIGS. 4, 5), creating another area for fluid pooling. This depressed electrode 142a, 142b surface can also prevent wear of the electrodes 142a, 142b. Pooling of fluid at the electrodes 142a, 142b allows for effective interaction between the fluid and the electrodes which in turn can provide effective and advantageous sealing of tissue, and in particular may provide effective Transcollation® sealing of tissue.


With continued reference to FIG. 1, electrodes 142a and 142b are situated in an area generally centrally located with respect to the outer shaft opening 134 when inner shaft cutter 141 is in a downward position. This generally central location of the electrodes 142a, 142b allows for energy delivery at an optimal point of debridement. In other words, after inner shaft cutter 141 and outer shaft cutter 132 are rotated or oscillated relative to one another to cut tissue, rotating inner shaft cutter 141 to the downward position to expose electrodes 142a, 142b and deliver energy through the electrodes 142a, 142b may allow for hemostasis in an area generally central to where debridement or cutting of tissue had taken place. The generally centered electrodes 142a, 142b allow for energy to essentially travel or radiate outwardly from the electrodes 142a, 142b to coagulate the approximately the entire area of tissue previously cut. In other words, energy, and particularly RF energy may be provided at the center or near center of a portion of tissue previously cut or debrided.



FIGS. 8 and 9 depict an alternative outer shaft 130 and inner shaft 140 whereby an outer shaft window or opening 134a is essentially enlarged as compared to outer shaft window 134 (FIG. 2) via a proximal window portion 138. This enlarged opening 134a may afford an inner shaft 140 having significantly larger electrodes 142c, 142d, such as depicted in FIG. 9. Electrodes 142c, 142d may be otherwise constructed similar to electrodes 142a and 142b (e.g., FIG. 2) and the remaining portions of inner shaft 140 may be constructed as described above.



FIG. 10 depicts a section of proximal assembly 168 of inner shaft 140 which section, when assembled in device 100, is generally situated within button activation assembly 200 (FIG. 1). Electrodes 142a and 142b are shown as individual traces separated by proximal assembly shaft component 169, which isolates the electrode traces 142a, 142b from one another. Electrodes 142a includes a proximal portion comprising a partial ring 300 extending at least partially circumferentially around proximal assembly shaft component 169. Likewise electrode 142b comprises a proximal portion comprising a ring 301 which may extend fully circumferentially around proximal assembly shaft component 169 as depicted in FIG. 10. Rings 300 and 301 provide contact surface area for electrical contacts such as clips 216a, 216b (FIGS. 12, 14).



FIGS. 11-14 depict the button activation assembly 200 and the way in which energy provided to electrodes 142a, 142b. FIG. 11 shows a partial cutaway view of the button activation assembly 200 one housing half 204b (FIG. 12) removed such that only housing half 204a is shown leaving portions of the button activation assembly 200 exposed. As shown in FIG. 11, at the proximal end region 110 of device 100 is provided a fluid housing 156 connected to the fluid connector 150 and an electrical contact housing 210 connected to the power source connector 160. The power source connector 160 is in turn coupled to a power cord or cable 161 comprising wires 161a, 161b and 161c. Power cord 161 is coupled to a printed circuit board (PCB) 206 via wires 161a, 161b and 161c. In addition, electrical contacts 164 and 166 electrically couple the power cord to caps 208a and 208b, as further explained with reference top FIGS. 12-14.



FIG. 12 shows and exploded view of the button activation cell 200 of FIG. 11 as well as a portion of proximal end region 110 with portions of the button activation cell removed. FIG. 13 shows an enlarged view of the portion of proximal end region 110 shown in FIG. 13 with still further portions removed. With reference between FIGS. 12-14, FIG. 12 shows two housing halves 204a and 204b which may be attached via any attachment device such as screws 400 and may, as described above, house various components of the button activation cell 200 as well as the fluid housing, electrical contact housing 210 and clip housing 220. Also depicted in FIG. 12 are o-rings 158a, 15b are adjacent fluid housing 156 and an o-ring 228 which is adjacent housing 220 for sealing fluid from the various components, including the electrical components provided in electrical contact housing 210.


Clip housing 220, shown alone or apart from cell 200 in FIG. 12, comprises two windows 224a, 224b. Clips 216a and 216b are provided in windows 224a, 224b with a flag 218a, 218b of each clip 216a and 216b viewable through or adjacent to windows 224a, 224b, such as depicted in assembled form in FIG. 13. Attached to clip housing 220 are two retaining rings 222a, 222b, for retaining the clips 216a and 216b in housing 220. As best seen in FIG. 14, post connectors 214a, 214b are coupled to clip flags 218a, 218b and provided on post connectors 214a, 214b are springs 212a, 212b. Over post connectors 214a, 214b and springs 212a, 212b are provided caps 208a, 208b. Also as best seen in FIG. 14, clips 216a and 216b are coupled to an in contact with rings 300 and 301 respectively of electrode traces 142a, 142b. Clips 216a, 216b, post connectors 214a,b, springs 212a, 212b and caps 208a, 208b are made of an electrically conductive material and provide electrical contact of the caps 208a, 208b to rings 300 and 301 when a source of power is activated or applied at caps 208a, 208b. As seen in FIGS. 11 and 12, the caps 208a, 208b are provided under the PCB 206, over which is provided button 202. Depressing button 202 drives a button contact assembly 203 which in turn moves to close circuitry of the PCB 206 allowing a pathway for current to flow from the power source 162 thus providing power to the electrodes 142a, 142b through the clips 216a, 216b as described above.


When energy is activated or applied to clips 216a, 216b, due to the intimate contact of clips 216a and 216b with electrode rings 300 and 301, electrical communication with bipolar electrodes 142a, 142b is achieved whereby energy is delivered along electrode traces 142a and 142b to the distal end 120 of device 100 and is applied to a targeted area of tissue as described herein above. This aspect of the present disclosure integrates electrodes 142a and 142b to the inner shaft 140 while isolating the inner shaft and electrodes 142a and 142b from other components and while distributing the required power to two separate and distinct electrodes 142a, 142b. This design also minimizes the number of layers required to make the distal end 120 of the device.



FIG. 15 is a top view of the button activation assembly 200 and depicts an alignment fiducial 420 through a window 430 in housing 204. Alignment fiducial 420 is provided on housing 221 (FIG. 13). The alignment fiducial 420 is one of two fiducials which may be provided on device 100, with the second fiducial not shown. Alignment fiducials (e.g., 420) are provided as indicators of alignment of inner cutter 141 and may be colored to indicate a particular alignment configuration.


Various modifications and alterations to this disclosure will become apparent to those skilled in the art without departing from the scope and spirit of this disclosure. It should be understood that this disclosure is not intended to be unduly limited by the illustrative embodiments and examples set forth herein and that such examples and embodiments are presented by way of example only with the scope of the disclosure intended to be limited only by the claims set forth herein as follows.

Claims
  • 1. An electrosurgical debridement device, comprising: an outer shaft defining a window;an inner shaft disposed within the outer shaft;a clip housing configured to receive a proximal end portion of the inner shaft, the clip housing defining a first window and a second window;a first electrode disposed on the inner shaft and removably connected to a first clip disposed within the clip housing, the first electrode configured to be exposed through the window defined by the outer shaft;a second electrode disposed on the inner shaft and removably connected to a second clip disposed within the clip housing, the second electrode configured to be exposed through the window defined by the outer shaft, wherein at least a portion of the first clip is exposed through the first window defined by the clip housing and at least a portion of the second clip is exposed through the second window defined by the clip housing; andan actuator coupled to the clip housing and configured to simultaneously complete an electrical pathway between the first clip and a power source and the second clip and the power source such that power is delivered from the power source simultaneously to the first and second electrodes.
  • 2. The electrosurgical debridement device according to claim 1, wherein the actuator is operably coupled to the exposed portions of the first and second clips.
  • 3. The electrosurgical debridement device according to claim 1, wherein the first window defined by the clip housing is axially spaced from the second window defined by the clip housing along a longitudinal axis defined by the inner shaft.
  • 4. The electrosurgical debridement device according to claim 1, wherein the first and second electrodes are electrically isolated from each other.
  • 5. The electrosurgical debridement device according to claim 1, wherein at least a portion of the first and second electrodes is a partial ring disposed around the inner shaft.
  • 6. The electrosurgical debridement device according to claim 1, further comprising first and second rings coupled to the clip housing and configured to retain the respective first and second clips within the clip housing.
  • 7. The electrosurgical debridement device according to claim 1, wherein the first clip includes a first flag viewable through the first window defined by the clip housing and the second clip includes a second flag viewable through the second window defined by the clip housing.
  • 8. The electrosurgical debridement device according to claim 1, wherein the outer shaft defines a lumen configured to be in fluid communication with a fluid source.
  • 9. The electrosurgical debridement device according to claim 8, further comprising a fluid channel disposed between an outer surface of the inner shaft and an inner surface of the outer shaft, the fluid channel configured to receive fluid from the fluid source for enabling pooling of the fluid at the window defined by the outer shaft.
  • 10. An electrosurgical debridement device, comprising: an outer shaft defining a window;an inner shaft disposed within the outer shaft;a clip housing configured to receive a proximal end portion of the inner shaft, the clip housing defining a first window and a second window;a first electrode disposed on the inner shaft and removably connected to a first clip disposed within the clip housing, the first electrode configured to be exposed through the window defined by the outer shaft;a second electrode disposed on the inner shaft and removably connected to a second clip disposed within the clip housing, the second electrode configured to be exposed through the window defined by the outer shaft; andan actuator coupled to the clip housing and configured to simultaneously complete an electrical pathway between the first clip and a power source and the second clip and the power source such that power is delivered from the power source simultaneously to the first and second electrodes.
  • 11. The electrosurgical debridement device according to claim 10, wherein the first window defined by the clip housing is axially spaced from the second window defined by the clip housing along a longitudinal axis defined by the inner shaft.
  • 12. The electrosurgical debridement device according to claim 10, wherein the first and second electrodes are electrically isolated from each other.
  • 13. The electrosurgical debridement device according to claim 10, wherein at least a portion of the first clip is exposed through the first window defined by the clip housing and at least a portion of the second clip is exposed through the second window defined by the clip housing.
  • 14. The electrosurgical debridement device according to claim 13, wherein the actuator is operably coupled to the exposed portions of the first and second clips.
  • 15. The electrosurgical debridement device according to claim 10, further comprising a fluid channel disposed between an outer surface of the inner shaft and an inner surface of the outer shaft, the fluid channel configured to receive a fluid from a fluid source for enabling pooling of the fluid at the window defined by the outer shaft.
  • 16. An electrosurgical debridement device, comprising: an outer shaft defining a window;an inner shaft disposed within the outer shaft;a clip housing defining a window and configured to receive a proximal end portion of the inner shaft;at least one electrode disposed on the inner shaft and having a proximal end portion removably connected to a clip disposed within the clip housing and a distal end portion configured to be exposed through the window defined by the outer shaft, wherein at least a portion of the clip is exposed through the window defined by the clip housing; andan actuator coupled to the exposed portion of the clip, wherein movement of the actuator to an activation position is configured to complete an electrical pathway between the clip and a power source such that power is delivered from the power source to the at least one electrode.
  • 17. The electrosurgical debridement device according to claim 16, wherein the at least one electrode includes first and second electrodes electrically isolated from each other.
  • 18. The electrosurgical debridement device according to claim 17, wherein movement of the actuator to the activation position causes power from the power source to be delivered simultaneously to the first and second electrodes.
  • 19. The electrosurgical debridement device according to claim 16, wherein the clip includes a flag viewable through the window defined by the clip housing.
  • 20. The electrosurgical debridement device according to claim 16, further comprising a fluid channel disposed between an outer surface of the inner shaft and an inner surface of the outer shaft, the fluid channel configured to receive a fluid from a fluid source for enabling pooling of the fluid at the window defined by the outer shaft.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/847,121, filed on Apr. 13, 2020, which is a continuation of U.S. patent application Ser. No. 14/951,697, filed on Nov. 25, 2015, now U.S. Pat. No. 10,653,478, which is a continuation of U.S. patent application Ser. No. 13/916,127, filed on Jun. 12, 2013, now U.S. Pat. No. 9,226,792, which claims the benefit of the filing dates of provisional U.S. Patent Application No. 61/658,724, filed on Jun. 12, 2012, and provisional U.S. Patent Application No. 61/704,904, filed on Sep. 24, 2012.

US Referenced Citations (443)
Number Name Date Kind
2888928 Seiger Jun 1959 A
3191084 Hiroshi et al. Jun 1965 A
3223088 Barber et al. Dec 1965 A
3682130 Jeffers Aug 1972 A
3750650 Ruttgers Aug 1973 A
3886944 Jamshidi Jun 1975 A
3955284 Balson May 1976 A
3955578 Chamness May 1976 A
4014342 Staub et al. Mar 1977 A
4060088 Morrison, Jr. et al. Nov 1977 A
4174713 Mehl Nov 1979 A
4195637 Gruntzig et al. Apr 1980 A
4207897 Lloyd et al. Jun 1980 A
4248224 Jones Feb 1981 A
4651734 Doss et al. Mar 1987 A
4823791 D'Amelio et al. Apr 1989 A
4878493 Pasternak et al. Nov 1989 A
4932952 Wojciechowicz, Jr. Jun 1990 A
4943290 Rexroth et al. Jul 1990 A
4950232 Ruzicka et al. Aug 1990 A
4985030 Melzer et al. Jan 1991 A
4998933 Eggers et al. Mar 1991 A
5112299 Pascaloff May 1992 A
5190541 Abele et al. Mar 1993 A
5195959 Smith Mar 1993 A
5230704 Moberg et al. Jul 1993 A
5234428 Kaufman Aug 1993 A
5254117 Rigby et al. Oct 1993 A
5275609 Pingleton et al. Jan 1994 A
5281215 Milder Jan 1994 A
5282799 Rydell Feb 1994 A
5330521 Cohen Jul 1994 A
5334181 Rubinsky et al. Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5336443 Odashima Aug 1994 A
5352222 Rydell Oct 1994 A
5364395 West, Jr. Nov 1994 A
5376078 Dinger, III et al. Dec 1994 A
5383874 Jackson et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5395312 Desai Mar 1995 A
5401272 Perkins Mar 1995 A
5405348 Anspach, Jr. et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5413556 Whittingham May 1995 A
5417709 Slater May 1995 A
5431168 Webster, Jr. Jul 1995 A
5431649 Mulier et al. Jul 1995 A
5441503 Considine et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5460629 Shlain et al. Oct 1995 A
5490819 Nicholas et al. Feb 1996 A
5492527 Glowa et al. Feb 1996 A
5496271 Burton et al. Mar 1996 A
5505700 Leone et al. Apr 1996 A
5540562 Giter Jul 1996 A
5540708 Lim et al. Jul 1996 A
5542196 Kantro Aug 1996 A
5542945 Fritzsch Aug 1996 A
5556397 Long et al. Sep 1996 A
5560373 De Santis Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5569243 Kortenbach et al. Oct 1996 A
5569254 Carlson et al. Oct 1996 A
5573424 Poppe Nov 1996 A
5595183 Swanson et al. Jan 1997 A
5599346 Edwards et al. Feb 1997 A
5605539 Buelna et al. Feb 1997 A
5609573 Sandock Mar 1997 A
5620415 Lucey et al. Apr 1997 A
5620447 Smith et al. Apr 1997 A
5647869 Goble et al. Jul 1997 A
5676693 LaFontaine Oct 1997 A
5685838 Peters et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5697536 Eggers et al. Dec 1997 A
5712543 Sjostrom Jan 1998 A
5713942 Stern et al. Feb 1998 A
5733280 Avitall Mar 1998 A
5743903 Stern et al. Apr 1998 A
5766167 Eggers et al. Jun 1998 A
5792167 Kablik et al. Aug 1998 A
5797905 Fleischman et al. Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5810764 Eggers et al. Sep 1998 A
5810802 Panescu et al. Sep 1998 A
5810809 Rydell Sep 1998 A
5814044 Hooven Sep 1998 A
5827216 Igo et al. Oct 1998 A
5836947 Fleischman et al. Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5843021 Edwards et al. Dec 1998 A
5843152 Tu et al. Dec 1998 A
5849023 Mericle Dec 1998 A
5873855 Eggers et al. Feb 1999 A
5873886 Larsen et al. Feb 1999 A
5891142 Eggers et al. Apr 1999 A
5895355 Schaer Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5899915 Saadat May 1999 A
5902272 Eggers et al. May 1999 A
5904681 West, Jr. May 1999 A
5913854 Maguire et al. Jun 1999 A
5916150 Sillman Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5921982 Lesh et al. Jul 1999 A
5925045 Reimels et al. Jul 1999 A
5927284 Borst et al. Jul 1999 A
5928191 Houser et al. Jul 1999 A
5935123 Edwards et al. Aug 1999 A
5941876 Nardella et al. Aug 1999 A
5944715 Goble et al. Aug 1999 A
5957881 Peters et al. Sep 1999 A
5957919 Laufer Sep 1999 A
5971980 Sherman Oct 1999 A
5971983 Lesh Oct 1999 A
5980516 Mulier et al. Nov 1999 A
5989248 Tu et al. Nov 1999 A
5993412 Deily et al. Nov 1999 A
6004316 Laufer Dec 1999 A
6004319 Goble et al. Dec 1999 A
6010476 Saadat Jan 2000 A
6010500 Sherman et al. Jan 2000 A
6012457 Lesh Jan 2000 A
6015391 Rishton et al. Jan 2000 A
6024733 Eggers et al. Feb 2000 A
6042556 Beach et al. Mar 2000 A
6042593 Storz et al. Mar 2000 A
6053923 Veca et al. Apr 2000 A
6063081 Mulier et al. May 2000 A
6071279 Whayne et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6088894 Oakley Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6117101 Diederich et al. Sep 2000 A
6142993 Whayne et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6152941 Himes et al. Nov 2000 A
6161543 Cox et al. Dec 2000 A
6165174 Jacobs et al. Dec 2000 A
6193715 Wrublewski et al. Feb 2001 B1
6197024 Sullivan Mar 2001 B1
6214003 Morgan et al. Apr 2001 B1
6217528 Koblish et al. Apr 2001 B1
6217576 Tu et al. Apr 2001 B1
6217598 Berman et al. Apr 2001 B1
6221088 Bays Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6235024 Tu May 2001 B1
6237605 Vaska et al. May 2001 B1
6238347 Nix et al. May 2001 B1
6238393 Mulier May 2001 B1
6245061 Panescu et al. Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6245065 Panescu et al. Jun 2001 B1
6246638 Zook et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251128 Knopp et al. Jun 2001 B1
6270471 Hechel et al. Aug 2001 B1
6292689 Wallace et al. Sep 2001 B1
6293943 Panescu et al. Sep 2001 B1
6293957 Peters et al. Sep 2001 B1
6296638 Davison et al. Oct 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328736 Mulier Dec 2001 B1
6332881 Carner et al. Dec 2001 B1
6342061 Kauker et al. Jan 2002 B1
6358248 Mulier et al. Mar 2002 B1
6361531 Hissong Mar 2002 B1
6364876 Erb et al. Apr 2002 B1
6368275 Sliwa et al. Apr 2002 B1
6383151 Diederich et al. May 2002 B1
6385472 Hall et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6413254 Hissong et al. Jul 2002 B1
6419648 Vitek et al. Jul 2002 B1
6425867 Vaezy et al. Jul 2002 B1
6430426 Avitall Aug 2002 B2
6440130 Mulier et al. Aug 2002 B1
6443952 Mulier et al. Sep 2002 B1
6454782 Schwemberger Sep 2002 B1
6461357 Sharkey et al. Oct 2002 B1
6471697 Lesh Oct 2002 B1
6471698 Edwards et al. Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6475216 Mulier et al. Nov 2002 B2
6477396 Mest et al. Nov 2002 B1
6484727 Vaska et al. Nov 2002 B1
6488678 Sherman Dec 2002 B2
6488680 Francischelli et al. Dec 2002 B1
6494892 Ireland et al. Dec 2002 B1
6502575 Jacobs et al. Jan 2003 B1
6503263 Adams Jan 2003 B2
6514250 Jahns et al. Feb 2003 B1
6527767 Wang et al. Mar 2003 B2
6537248 Muller Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6558382 Jahns May 2003 B2
6558385 McClurken et al. May 2003 B1
6565560 Goble et al. May 2003 B1
6565561 Goble et al. May 2003 B1
6584360 Francischelli Jun 2003 B2
6585732 Muller Jul 2003 B2
6605084 Acker et al. Aug 2003 B2
6610055 Swanson et al. Aug 2003 B1
6610059 West, Jr. Aug 2003 B1
6610060 Mulier et al. Aug 2003 B2
6613048 Mulier et al. Sep 2003 B2
6623500 Cook et al. Sep 2003 B1
6645199 Jenkins et al. Nov 2003 B1
6648883 Francischelli et al. Nov 2003 B2
6656175 Francischelli et al. Dec 2003 B2
6663627 Francischelli et al. Dec 2003 B2
6663628 Peters Dec 2003 B2
6689131 McClurken Feb 2004 B2
6699240 Francischelli Mar 2004 B2
6702810 McClurken et al. Mar 2004 B2
6702811 Stewart et al. Mar 2004 B2
6706038 Francischelli et al. Mar 2004 B2
6706039 Muller Mar 2004 B2
6716211 Muller Apr 2004 B2
6716215 David et al. Apr 2004 B1
6736810 Hoey et al. May 2004 B2
6752816 Culp et al. Jun 2004 B2
6755827 Muller Jun 2004 B2
6764487 Mulier et al. Jul 2004 B2
6773433 Stewart et al. Aug 2004 B2
6776780 Mulier et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6807968 Francischelli Oct 2004 B2
6824550 Noriega et al. Nov 2004 B1
6827715 Francischelli et al. Dec 2004 B2
6849073 Hoey et al. Feb 2005 B2
6858028 Mulier et al. Feb 2005 B2
6887238 Jahns May 2005 B2
6899711 Stewart et al. May 2005 B2
6911019 Muller Jun 2005 B2
6916318 Francischelli et al. Jul 2005 B2
6923803 Goble Aug 2005 B2
6936046 Hissong et al. Aug 2005 B2
6949097 Stewart et al. Sep 2005 B2
6949098 Muller Sep 2005 B2
6953461 McClurken et al. Oct 2005 B2
6960205 Jahns Nov 2005 B2
6962589 Muller Nov 2005 B2
6979332 Adams Dec 2005 B2
7052494 Goble et al. May 2006 B2
7115139 McClurken et al. Oct 2006 B2
7150747 McDonald et al. Dec 2006 B1
7166103 Carmel et al. Jan 2007 B2
7179255 Lettice et al. Feb 2007 B2
7229437 Johnson et al. Jun 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7237990 Deng Jul 2007 B2
7247155 Hoey et al. Jul 2007 B2
7247161 Johnston et al. Jul 2007 B2
7261711 Mulier et al. Aug 2007 B2
7276074 Adams et al. Oct 2007 B2
7278994 Goble Oct 2007 B2
7309325 Mulier et al. Dec 2007 B2
7311708 McClurken Dec 2007 B2
7322974 Swoyer et al. Jan 2008 B2
7361175 Suslov Apr 2008 B2
7364579 Mulier et al. Apr 2008 B2
7416539 Johnston et al. Aug 2008 B2
7442191 Hovda et al. Oct 2008 B2
7537595 McClurken May 2009 B2
7604635 McClurken et al. Oct 2009 B2
7608072 Swanson Oct 2009 B2
7645277 McClurken et al. Jan 2010 B2
7651494 McClurken et al. Jan 2010 B2
7674263 Ryan Mar 2010 B2
7691050 Gellman et al. Apr 2010 B2
7699846 Ryan Apr 2010 B2
7736361 Palanker et al. Jun 2010 B2
7749608 Laude et al. Jul 2010 B2
7785337 Adams et al. Aug 2010 B2
7811282 McClurken Oct 2010 B2
7815634 McClurken et al. Oct 2010 B2
7854736 Ryan Dec 2010 B2
7909820 Lipson et al. Mar 2011 B2
7942872 Ein-Gal May 2011 B2
7976544 McClurken et al. Jul 2011 B2
7993337 Lesh Aug 2011 B2
7997278 Utley et al. Aug 2011 B2
7998140 McClurken et al. Aug 2011 B2
8012153 Woloszko et al. Sep 2011 B2
8034071 Scribner et al. Oct 2011 B2
8038670 McClurken Oct 2011 B2
8048070 O'Brien et al. Nov 2011 B2
8083736 McClurken et al. Dec 2011 B2
8105323 Buysse et al. Jan 2012 B2
8109956 Shadeck Feb 2012 B2
8172828 Chang et al. May 2012 B2
8177783 Davison et al. May 2012 B2
8202288 Adams et al. Jun 2012 B2
8216233 McClurken et al. Jul 2012 B2
8277474 Norman et al. Oct 2012 B2
8317786 Dahla et al. Nov 2012 B2
8323276 Palanker et al. Dec 2012 B2
8348946 McClurken et al. Jan 2013 B2
8361068 McClurken Jan 2013 B2
8377086 Flynn et al. Feb 2013 B2
8388642 Muni et al. Mar 2013 B2
8414572 Davison et al. Apr 2013 B2
8568419 de Wekker Oct 2013 B2
9226792 Bloom Jan 2016 B2
10653478 Bloom May 2020 B2
11737812 Bloom Aug 2023 B2
20010047183 Privitera et al. Nov 2001 A1
20020038129 Peters et al. Mar 2002 A1
20020049483 Knowlton Apr 2002 A1
20020062131 Gallo May 2002 A1
20020082643 Milla et al. Jun 2002 A1
20020165549 Owusu-Akyaw et al. Nov 2002 A1
20030014050 Sharkey et al. Jan 2003 A1
20030032954 Carranza et al. Feb 2003 A1
20030045872 Jacobs Mar 2003 A1
20030073993 Ciarrocca Apr 2003 A1
20030097129 Davison et al. May 2003 A1
20030144656 Ocel Jul 2003 A1
20030165794 Matoba Sep 2003 A1
20030191462 Jacobs Oct 2003 A1
20030204185 Sherman et al. Oct 2003 A1
20030216724 Jahns Nov 2003 A1
20040010258 Carusillo et al. Jan 2004 A1
20040015106 Coleman Jan 2004 A1
20040015219 Francischelli Jan 2004 A1
20040024395 Ellman et al. Feb 2004 A1
20040044340 Francischelli Mar 2004 A1
20040049179 Francischelli et al. Mar 2004 A1
20040078069 Francischelli Apr 2004 A1
20040082948 Stewart et al. Apr 2004 A1
20040087940 Jahns et al. May 2004 A1
20040092926 Hoey May 2004 A1
20040111136 Sharkey et al. Jun 2004 A1
20040111137 Sharkey et al. Jun 2004 A1
20040116923 Desinger Jun 2004 A1
20040138621 Jahns Jul 2004 A1
20040138656 Francischelli Jul 2004 A1
20040143260 Francischelli Jul 2004 A1
20040153057 Davison Aug 2004 A1
20040167427 Quick et al. Aug 2004 A1
20040186465 Francischelli Sep 2004 A1
20040215183 Hoey et al. Oct 2004 A1
20040220560 Briscoe Nov 2004 A1
20040236322 Muller Nov 2004 A1
20040243163 Casiano et al. Dec 2004 A1
20040267326 Ocel et al. Dec 2004 A1
20050010095 Stewart et al. Jan 2005 A1
20050033280 Francischelli Feb 2005 A1
20050090815 Francischelli Apr 2005 A1
20050090816 McClurken et al. Apr 2005 A1
20050143729 Francischelli Jun 2005 A1
20050165392 Francischelli Jul 2005 A1
20050171525 Rioux et al. Aug 2005 A1
20050209564 Bonner et al. Sep 2005 A1
20050222566 Nakahira Oct 2005 A1
20050267454 Hissong Dec 2005 A1
20050277970 Norman et al. Dec 2005 A1
20060009756 Francischelli et al. Jan 2006 A1
20060009759 Chrisitian et al. Jan 2006 A1
20060064085 Schechter et al. Mar 2006 A1
20060106375 Werneth et al. May 2006 A1
20060200123 Ryan Sep 2006 A1
20060259055 Thorne et al. Nov 2006 A1
20070049920 McClurken et al. Mar 2007 A1
20070093808 Mulier et al. Apr 2007 A1
20070100336 McFarlin et al. May 2007 A1
20070118114 Miller et al. May 2007 A1
20070149965 Gallo et al. Jun 2007 A1
20070179495 Mitchell et al. Aug 2007 A1
20070208332 Mulier et al. Sep 2007 A1
20080015563 Hoey et al. Jan 2008 A1
20080042513 Kuenzel et al. Feb 2008 A1
20080058796 O'Brien et al. Mar 2008 A1
20080071270 Desinger et al. Mar 2008 A1
20080132890 Woloszko et al. Jun 2008 A1
20080207028 Schutz Aug 2008 A1
20080262489 Steinke Oct 2008 A1
20090118729 Auth et al. May 2009 A1
20090264879 McClurken et al. Oct 2009 A1
20090270896 Sullivan Oct 2009 A1
20090306655 Stangenes et al. Dec 2009 A1
20100087812 Davison et al. Apr 2010 A1
20100100095 McClurken et al. Apr 2010 A1
20100160906 Jarrard Jun 2010 A1
20100241178 Tilson et al. Sep 2010 A1
20100298763 Adams et al. Nov 2010 A1
20100298855 Dierck Nov 2010 A1
20100317998 Hibner et al. Dec 2010 A1
20110009856 Jorgensen et al. Jan 2011 A1
20110017801 Zemlok et al. Jan 2011 A1
20110017851 Lunde et al. Jan 2011 A1
20110028965 McClurken et al. Feb 2011 A1
20110066142 Tal et al. Mar 2011 A1
20110077648 Lee et al. Mar 2011 A1
20110112366 Basit May 2011 A1
20110137298 Nguyen et al. Jun 2011 A1
20110196367 Gallo Aug 2011 A1
20110295249 Bloom et al. Dec 2011 A1
20110301578 Muniz-Medina et al. Dec 2011 A1
20110319889 Chojin et al. Dec 2011 A1
20120004657 Conley et al. Jan 2012 A1
20120071712 Manwaring et al. Mar 2012 A1
20120101496 McClurken et al. Apr 2012 A1
20120109130 Casey et al. May 2012 A1
20120116261 Mumaw et al. May 2012 A1
20120116397 Rencher et al. May 2012 A1
20120143293 Mauch et al. Jun 2012 A1
20120150165 Conley et al. Jun 2012 A1
20120157989 Stone et al. Jun 2012 A1
20120172877 Ryan et al. Jul 2012 A1
20120179158 Stierman Jul 2012 A1
20120184983 Chang et al. Jul 2012 A1
20120191084 Davison et al. Jul 2012 A1
20120191117 Palmer et al. Jul 2012 A1
20120215245 Palmer et al. Aug 2012 A1
20120221035 Harvey Aug 2012 A1
20120253343 McClurken et al. Oct 2012 A1
20130004595 Bhatia Jan 2013 A1
20130053830 Edwards et al. Feb 2013 A1
20130085498 Matusaitis et al. Apr 2013 A1
20130144288 Ryan Jun 2013 A1
20130331833 Bloom Dec 2013 A1
20130345704 Palmer et al. Dec 2013 A1
20140005700 Casey et al. Jan 2014 A1
20140100567 Edwards et al. Apr 2014 A1
20140132126 Vicars et al. May 2014 A1
20140155888 Edwards et al. Jun 2014 A1
20140155889 Edwards et al. Jun 2014 A1
20140155923 Edwards Jun 2014 A1
20140207217 Lischinsky et al. Jul 2014 A1
20140276808 Gittard et al. Sep 2014 A1
20140277036 Flynn et al. Sep 2014 A1
20150265337 Bloom Sep 2015 A1
20160235468 Prisco et al. Aug 2016 A1
20160235469 Prisco et al. Aug 2016 A1
20160235474 Prisco et al. Aug 2016 A1
Foreign Referenced Citations (18)
Number Date Country
2323742 Jun 1999 CN
1222065 Jul 1999 CN
103096828 Jul 2016 CN
1201196 May 2002 EP
1853187 Nov 2007 EP
2044893 Aug 2009 EP
2133028 Dec 2009 EP
247060 Feb 1926 GB
9637156 Nov 1996 WO
9723169 Jul 1997 WO
9834550 Aug 1998 WO
9838932 Sep 1998 WO
03079911 Oct 2003 WO
2011037664 Mar 2011 WO
2012102838 Aug 2012 WO
2013191811 Dec 2013 WO
2014084983 Jun 2014 WO
2014133663 Sep 2014 WO
Non-Patent Literature Citations (13)
Entry
Final Office Action for U.S. Appl. No. 15/047,242 dated May 28, 2020 (11 pages).
Notice of Allowance for U.S. Appl. No. 15/046,853 dated Apr. 3, 2019 (11 pages).
Non-Final Office Action for U.S. Appl. No. 15/047,242 dated Apr. 11, 2019 (28 pages).
Non-Final Office Action for U.S. Appl. No. 15/046,853 dated Oct. 25, 2018 (39 pages).
Final Office Action for U.S. Appl. No. 15/047,242 dated Jan. 25, 2019 (20 pages).
Notice of Allowance for U.S. Appl. No. 15/046,869 dated Oct. 9, 2018 (23 pages).
Non-Final Office Action for U.S. Appl. No. 15/047,242 dated Aug. 21, 2019 (14 pages).
Non-Final Office Action for U.S. Appl. No. 15/046,853 dated Apr. 12, 2018 (38 pages).
Non-Final Office Action for U.S. Appl. No. 15/046,869 dated Mar. 28, 2018 (29 pages).
International Search Report and Written Opinion dated May 3, 2016 for International Application No. PCT/ US2016/018486 (12 pages).
Non-Final Office Action for U.S. Appl. No. 15/047,242 dated Jul. 10, 2018 (32 pages).
Final Office Action for U.S. Appl. No. 15/047,242 dated Apr. 28, 2021 (11 pages).
Final Office Action for U.S. Appl. No. 15/047,242 dated Feb. 21, 2020 (11 pages).
Related Publications (1)
Number Date Country
20230380889 A1 Nov 2023 US
Provisional Applications (2)
Number Date Country
61704904 Sep 2012 US
61658724 Jun 2012 US
Continuations (3)
Number Date Country
Parent 16847121 Apr 2020 US
Child 18448213 US
Parent 14951697 Nov 2015 US
Child 16847121 US
Parent 13916127 Jun 2013 US
Child 14951697 US